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Experimental evidence documents that nutritional phytoestrogens may interact with reproductive functions but the exact
mechanism of action is still controversial. Since quercetin is one of the main ﬂavonoids in livestock nutrition, we evaluated its
possible eﬀects on cultured swine granulosa cell proliferation, steroidogenesis, and redox status. Moreover, since angiogenesis is
essential for follicle development, the eﬀect of the ﬂavonoid on Vascular Endothelial Growth Factor output by granulosa cells was
also taken into account. Our data evidence that quercetin does not aﬀect granulosa cell growth while it inhibits progesterone
production and modiﬁes estradiol 17β production in a dose-related manner. Additionally, the ﬂavonoid interferes with the
angiogenic process by inhibiting VEGF production as well as by altering redox status. Since steroidogenesis and angiogenesis are
strictly involved in follicular development, these ﬁndings appear particularly relevant, pointing out a possible negative inﬂuence
of quercetin on ovarian physiology. Therefore, the possible reproductive impact of the ﬂavonoid should be carefully considered in
animal nutrition.
Copyright © 2009 Sujen Eleonora Santini et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Quercetin (3,30,40,5,7-pentahydroxyﬂavone) is a ﬂavonoid
belonging to a group of plant-derived nonsteroidal com-
pounds known as phytoestrogens [1]. In plants, these
compounds are involved in energy production and exhibit
strong antioxidant properties; in mammals, they have been
shown to exert various biological and pharmacological
eﬀects [2, 3]. Several studies [4–6] have demonstrated their
signiﬁcant health promoting activities, due to free radical
scavenging and metal chelating properties. On the other
hand,quercetincanalsoexhibitpro-oxidanteﬀects[7].Ithas
been demonstrated [8–11] a relationship between quercetin
free radical scavenging activity and its anticarcinogenic and
anti-inﬂammatory properties. Most experimental data about
the activity of ﬂavonoids in diﬀerent biological systems have
been obtained by in vitro studies, and the knowledge of the
pharmacokinetics and systemic availability of food-derived
ﬂavonoids in humans and animals is still incomplete: in
particular, the bioavailability of quercetin appears low, but
r e p o r t e dv a l u e sr a n g ef r o m0 %t o5 2 %[ 12, 13].
Recent data obtained in vitro or in animal studies
indicate that ﬂavonoids may also modify cell function inde-
pendently of their antioxidant power [14–16], aﬀecting the
overall process of carcinogenesis by diﬀerent mechanisms.
Since it is well known that neovascularization represents
a key process in tumor growth, invasion, and metastasis,
a lot of scientiﬁc interest has developed in recent years
about potential inhibitors of angiogenesis. Among natural
health products, dietary ﬂavonoids have shown to possess
antiangiogenic eﬀects, inhibiting several important steps of
new vessel growth: an impairment of VEGF expression by
diﬀerent ﬂavonoids has been documented [17, 18], as well as
inhibitoryeﬀectsonproliferation,migration,tubeformation
of endothelial cells in vitro [19–21].
In particular, many experimental evidences suggest a
close link between quercetin antineoplastic eﬀect and its
antiangiogenicpotential[22–25].Whileboththeantioxidant
and antiangiogenic properties of quercetin are generally
related to its protective eﬀects against oxidative stress and
should also be relevant for its cancer preventive impact
[11, 26], the potential of the inhibition of vessel formation2 Journal of Biomedicine and Biotechnology
on female reproductive eﬃciency remains elusive; in fact, it
is well known that the ovarian angiogenic process is strictly
associated with follicular development [27]. Furthermore,
ROSs play a crucial role in the ovarian follicle as signalling
molecules in both the angiogenic cascade [28] and the
ovulatory process. Additionally, phytoestrogens are able to
bind to estrogen receptors thus activating several estrogen-
responsive genes [3]. In particular, quercetin has been found
to exhibit both estrogenic and antiestrogenic actions in vitro
thus suggesting diﬀerent potential eﬀects on reproductive
function.
Therefore, the aim of this study was to evaluate possible
eﬀects of quercetin on the function of granulosa cells, which
play a complex and fundamental role in the development of
the ovarian follicle. To this purpose, we studied the ﬂavonoid
action on granulosa cell proliferation, steroidogeneis, and
redox status. Finally, since follicle growth requires new vessel
formation, we also evaluated the eﬀect of quercetin on the
production of VEGF, the main proangiogenic factor.
2.MaterialsandMethods
All the reagents were obtained from Sigma (St. Louis, Mo,
USA) unless otherwise speciﬁed.
2.1. Granulosa Cell Culture. Swine ovaries were collected
at a local slaughterhouse, placed into cold PBS (4◦C)
supplemented with penicillin (500IU/mL), streptomycin
(500μg/mL), and amphotericin B (3.75μg/mL), maintained
in a freezer bag and transported to the laboratory within
1hour. After two washings with PBS and ethanol (70%),
granulosa cells were aseptically harvested by aspiration from
follicles >5mm with a 26-gauge needle and released in
medium containing heparin (50IU/mL), centrifuged for
pelleting and then treated with 0.9% prewarmed ammo-
nium chloride at 37
◦C for 1minute to remove red blood
cells. Cell number and viability were estimated using a
haemocytometer under a phase contrast microscope after
vital staining with trypan blue (0.4%) of an aliquote of
cell suspension. Cells were seeded at diﬀerent densities (see
below) in culture medium (CM) represented by M199 sup-
plemented with sodium bicarbonate (2.2mg/mL), bovine
serum albumin (0.1%), penicillin (100UI/mL), strepto-
mycin (100μg/mL), amphotericin B (2.5μg/mL), selenium
(5ng/mL),andtransferrin(5μg/mL).Cellsweretreatedwith
quercetin (C15H10O7; CAS number 117-39-5; purity >95%;
Cayman Chemical, Michigan, USA) at the concentrations
of 5 or 50μg/mL and incubated at 37
◦C under humidiﬁed
atmosphere (5% CO2) for 48 hours.
Quercetin was dissolved in dimethyl sulfoxide (DMSO),
and the ﬁnal concentration of DMSO added to the medium
was 0.2% (vol/vol). The same concentration of DMSO was
added to speciﬁc control wells.
2.2. Granulosa Cell Proliferation. Cell proliferation was
evaluated by 5-bromo-2 -deoxyuridine (BrdU) incorpora-
tion assay test (Roche, Mannheim, Germany). Brieﬂy, 104
cell/200μL CM were seeded in 96-well plates and treated
as described above. After addition of 20μLB r d Ut oe a c h
well during the last 4hour of incubation, culture media
were removed, and DNA denaturing solution was added in
ordertoimprovetheaccessibilityoftheincorporateBrdUfor
antibody detection. Thereafter, 100μL anti-BrdU antibody
were added to each well. After a 1.5-hour incubation at
room temperature (21
◦C), the immune complexes were
detected by the subsequent substrate reaction. The reaction
product was quantiﬁed by measuring the absorbance at
450nmagainst690nmusingSpectraShellMicroplatereader
(SLT Spectra, Milan, Italy). To establish viable cell number,
absorbance was related to a standard curve prepared by
culturing in quintuplicate granulosa cells at diﬀerent plating
densities (from 103 to 105/200μL) for 48hours. The curve
was repeated in four diﬀerent experiments. The relationship
between cell number and absorbance was linear (r = 0.92).
Cell number/well was estimated from the resulting linear
regression equation. The assay detection limit was 103
cell/well, and the variation coeﬃcient was less than 5%. The
number of cells obtained by this calculation was used for
correcting hormones, VEGF production, and redox status
data.
2.3. Steroid Production. Brieﬂy, 104 cells/well were seeded in
96-well plates in 200μL CM supplemented with androstene-
dione (28ng/mL) and treated with quercetin at concentra-
tions previously described. Culture media were collected
after incubation, frozen and stored at −20
◦C until pro-
gesterone (P4) and 17β estradiol (E2) determination by
validated RIAs [29]. P4 assay sensitivity and ED50 were 0.24
and 1nM/L, respectively; E2 assay sensitivity and ED50 were
0.05 and 0.2nM/L. The intra- and interassay coeﬃcients of
variation were less than 12% for both assays.
2.4. Measurement of Reactive Oxygen Species
2.4.1. Nitric Oxide Production. Nitric oxide (NO) was
assessed by measuring nitrite levels in culture media by
microplate method based on the formation of a chro-
mophore after reaction with Greiss reagent, which was
prepared fresh daily by mixing equal volumes of stock A
(1% sulfanilamide, 5% phosphoric acid) and stock B (0.1%
N-[naphtyl] ethylenediamine dhydrochloride). Brieﬂy, 105
cells/200μL CM were seeded in 96-well plates and treated
with quercetin as already mentioned. After incubation with
Greiss reagent, the absorbance was determined with a
Spectra Shell Microplate Reader using a 540nm against
620nmﬁlter.Acalibrationcurverangingfrom25to0.39μM
was prepared by diluting sodium nitrite in culture medium.
2.4.2. Superoxide Anion Production. Superoxide anion (O2
−)
generation was measured by the cell proliferation WST-1
test (Roche, Mannheim, Germany). Brieﬂy, 105 cells/200μL
CM were seeded in 96-well plates and treated with quercetin
as described above. Since evidence exists [30, 31] that
tetrazolium salts can be used as a reliable measure of
intracellular O2
− production, 20 μLo fW S T - 1w e r ea d d e dt o
thecellduringthelast4hoursofincubation.Theabsorbance
was then determined using a Spectra Shell Microplate reader
at 450nm against 620nm.Journal of Biomedicine and Biotechnology 3
2.4.3. Hydrogen Peroxide Production. Hydrogen peroxide
(H2O2) production was measured by an Amplex Red Hydro-
gen Peroxide Assay Kit (Molecular Probes, PoortGebouw,
The Netherlands); the Amplex Red reagent reacts with
H2O2 to produce resoruﬁn, an oxidation product. Brieﬂy,
2 × 105 cells/200μL CM were seeded in 96-well plates.
After incubation with treatments, plates were centrifuged for
10minutes,at400 × g,thenthesupernatantswerediscarded
and cells were lysed by adding cold Triton 1% in Tris–HCl
(100 μL per well), incubating on ice for 30minutes. The test
was performed on cell lysates and read against a standard
curve of H2O2 ranging from 0.195 to 12.5 μM. A Spectra
Shell microplate reader set to read 540nm emission was used
to quantify the reaction product.
2.5. Scavenging Enzyme Activity
2.5.1. Superoxide Dismutase Activity . Superoxide dismutase
(SOD) activity was determined by an SOD Assay Kit
(Dojindo Molecular Technologies, Japan). Brieﬂy, 2 × 105
cells/200μL CM were seeded in 96-well plates and, after
treatments, the plates were centrifuged for 10minutes at
400×g. The supernatantswerediscarded and cellswerelysed
by adding cold Triton 1% in Tris–HCl (100 μL/105 cells)
and incubating on ice for 30minutes. Cell lysates were tested
without dilution, and a standard curve of SOD ranging from
0.156 to 20 U/mL was prepared. The colorimetric assay was
performed measuring formazan produced by the reaction
between a tetrazolium salt (WST-1) and a superoxide anion
(O2
−), produced by the reaction of an exogenous xantine
oxidase. The remaining O2
− is an indirect hint of the
endogenous SOD activity. The absorbance was determined
with a Spectra Shell Microplate Reader reading at 450nm
against 620nm.
2.5.2. Peroxidase Activity. Peroxidase activity was measured
by an Amplex Red Peroxidase Assay Kit (Molecular Probes,
PoortGebouw, The Netherlands) based on the formation of
an oxidation product (resoruﬁn) derived from the reaction
between H2O2 given in excess and the Amplex Red reagent.
Brieﬂy, 105 cells/200 μL CM were seeded in 96-well plates
and incubated in the conditions described above. After
centrifugation for 10minutes. at 400 × g, the supernatants
were discarded, and cells were lysed by adding cold Triton
1% in TRIS HCl (100μL/105 cells) and incubating on ice
for 30minutes. Cell lysates were used undiluted to perform
the test. The absorbance was determined with a Spectra
Shell Microplate Reader using a 540nm ﬁlter and read
against a standard curve of peroxidase ranging from 0.039
to 5mU/mL.
2.6. Scavenging Nonenzymatic Activity
2.6.1. FRAP Assay. FRAP assay is a colorimetric method
based on the ability of the antioxidant molecules to
reduce ferric-tripiridyltriazine (Fe3+TPTZ) to a ferrous form
(Fe2+TPTZ). Fe2+ is measured spectrophotometrically via
determination of its coloured complex with 2,4,6-Tris(2-
pyridyl)-s-triazine (Fe2+ TPTZ). TPTZ reagent was prepared
before use, mixing 25mL of acetate buﬀer, 2.5mL of 2,4,6-
Tris(2-pyridyl)-s-triazine (TPTZ) 10mM/L in HCl 40mM/L
and FeCl
3−6H2O solution.
Brieﬂy, 2 × 105 cells/200μL CM were seeded in 96-well
plates and treated as already described. At the end, plates
were centrifuged for 10minutes at 400 × g, supernatants
were discarded and cells were lysed by adding cold Triton
0.5% + PMSF in PBS (200μL/well), incubating on ice for
30minutes. The test was performed on 40 μLo fc e l ll y s a t e s
added to Fe3+ TPTZ reagent and then incubated at 37
◦Cf o r
30minutes. The absorbance of Fe2+ TPTZ was determined
by Spectra Shell Microplate Reader at 595nm. The ferric
reducing ability of cell lysates was calculated by plotting a
standard curve of absorbance against FeSO4−7H2O standard
solution.
2.7. VEGF Production. The VEGF content in culture media
was quantiﬁed by an ELISA (Quantikine, R & D System,
Minneapolis, Mich, USA); this assay, which was developed
for human VEGF detection, has been validated for pig VEGF
[32]. Brieﬂy, 106 cell/1mL CM were seeded in 24-well plates
and treated as described above. The assay sensitivity was
8.74pg/mL, and the intra and interassay CVs were always
less than 7%. The absorbance was determined with a Spectra
Shell Microplate using a 450nm ﬁlter.
2.8. Statistical Analysis. Each experiment was repeated at
least 4 times (6 replicates/treatment). Experimental data
are presented as mean ± SEM; statistical diﬀerences were
calculated with ANOVA using Statgraphics package (STSC
Inc., Rockville, Md, USA). When signiﬁcant diﬀerences were
found, means were compared by Scheﬀ` e’s F-test.
3. Results
3.1. Granulosa Cell Proliferation. BrdU incorporation assay
test showed that basal swine granulosa cell proliferation was
unaﬀected by both concentrations of quercetin.
3.2. Steroid Production. Basal steroid production by gran-
ulosa cells was 3.7 ± 0.6 and 71.8 ± 10.0ng/mL (mean
± S.E.M.) for E2 and P4, respectively. 50μg/mL quercetin
signiﬁcantly(P<. 001)inhibitedE2productionbygranulosa
cells; on the contrary, 5μg/mL signiﬁcantly increased E2
levels (Figure 1). Quercetin signiﬁcantly (P<. 001) inhibited
P4 production by granulosa cells with a dose-dependent
eﬀect (P<. 001) (Figure 2).
3.3. Reactive Oxygen Species Production
3.3.1. Nitric Oxide Production. In the control group, NO
b a s a ll e v e l sw e r e3 . 1 6± 0.3μM; 5μg/mL quercetin signiﬁ-
cantly inhibited (P<. 001) NO production, while 50μg/mL
signiﬁcantly increased (P<. 001) NO levels in granulosa cell
culture media (Figure 3).
3.3.2. Superoxide Anion Production. WST-1 assay showed
that50μg/mLquercetinsigniﬁcantly(P<. 05)inhibitedO2
−
production, while 5μg/mL were ineﬀective (Figure 4).4 Journal of Biomedicine and Biotechnology
0
50
100
150
200
E
2
p
r
o
d
u
c
t
i
o
n
(
%
v
e
r
s
u
s
C
)
C55 0
Quercetin (μg/mL)
a
b
c
Figure 1: Eﬀect of the 48-hour treatment with quercetin (5 and
50μg/mL) on Estradiol 17β (E2) production by swine granulosa
cell cultured in vitro. Data represent the mean ± SEM of six
replicates/treatment repeated in four diﬀerent experiments. Diﬀer-
ent letters indicate signiﬁcant diﬀerences (P< . 001) calculated
by ANOVA and Scheﬀ` e’s F-test (Statgraphics package, STSC Inc.,
Rockville, Md, USA).
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Figure 2: Eﬀect of the 48-hour treatment with quercetin (5 and
50μg/mL) on progesterone (P4) production by swine granulosa
cell cultured in vitro. Data represent the mean ± SEM of six
replicates/treatment repeated in four diﬀerent experiments. Diﬀer-
ent letters indicate signiﬁcant diﬀerences (P< . 001) calculated
by ANOVA and Scheﬀ` e’s F-test (Statgraphics package, STSC Inc.,
Rockville, Md, USA).
3.3.3. Hydrogen Peroxide Production. Colorimetric assay did
not show any signiﬁcant eﬀect of quercetin on H2O2
production by swine granulosa cell.
3.4. Scavenging Enzyme Activity
SuperoxideDismutaseandPeroxidaseActivity. BothSODand
peroxidase activities were unaﬀected by quercetin.
3.5. Scavenging Nonenzymatic Activity
FRAP Assay. FRAP assay showed that 50μg/mL quercetin
signiﬁcantly (P<. 001) increased the nonenzymatic antioxi-
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Figure 3: Eﬀect of the 48-hour treatment with quercetin (5 and
50μg/ml) on nitric oxide production (NO) by swine granulosa
cell cultured in vitro. Data represent the mean ± SEM of six
replicates/treatment repeated in four diﬀerent experiments. Diﬀer-
ent letters indicate signiﬁcant diﬀerences (P< . 001) calculated
by ANOVA and Scheﬀ` e’s F-test (Statgraphics package, STSC Inc.,
Rockville, Md, USA).
dant power in granulosa cell, while 5μg/mL were ineﬀective
(Figure 5).
3.6.VEGFProduction. VEGFproductionbyswinegranulosa
cell was signiﬁcantly (P<. 05) inhibited by both concentra-
tionsofquercetin;higherdoseproducedmoremarkedeﬀects
(P<. 001) (Figure 6).
4. Discussion
Phytoestrogen quercetin is abundant in many plants used
in animal nutrition [33, 34]. In recent years, this ﬂavonoid
has attracted a lot of interest, due to its putative health
promoting activities likely resulting from its antioxidant
eﬀects. Nevertheless, its overall biological impact remains
controversial, mostly because of limited information about
its bioavailability, endogenous dynamics, and the relative
contribution of diﬀerent types of conjugates in humans and
animals.Quercetin appearsto be eﬀectivein in vitro assaysat
concentrations ranging from 0.3 and 30 μg/mL, but plasma
levels resulting from high oral doses are generally below
those values [13]. This issue needs to be properly assessed in
future studies, in order to get a better insight on the optimal
consumption levels which could provide pharmacological
signiﬁcant concentrations in body ﬂuids and tissues.
Inourexperimentalmodel,highquercetinconcentration
(30 μg/ml) has also been tested, since a process of accu-
mulation of this ﬂavonoid in some body tissues cannot be
excluded [13].
Present study conﬁrms that quercetin can modulate
ovarian function, interfering with porcine granulosa cell
steroidogenic activity [35] .T h en e g a t i v ee ﬀe c to nP 4p r o -
duction could result from an inhibition of steroidogenic
enzymes [36, 37], since no detectable changes of cell
proliferation have been observed. In a previous work [37],Journal of Biomedicine and Biotechnology 5
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Figure 4: Eﬀect of the 48-hour treatment with quercetin (5
and 50μg/ml) on superoxide anion (O2
−) production by swine
granulosa cell cultured in vitro. Data represent the mean ± SEM
of six replicates/treatment repeated in four diﬀerent experiments.
Diﬀerent letters indicate signiﬁcant diﬀerences (P< . 05) calculated
by ANOVA and Scheﬀ` e’s F-test (Statgraphics package, STSC Inc.,
Rockville, Md, USA).
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Figure 5: Eﬀect of the 48-hour treatment with quercetin (5 and
50μg/ml) on Ferric Reducing Antioxidant Power (FRAP) levels
in swine granulosa cell cultured in vitro. Data represent the
mean ± SEM of six replicates/treatment repeated in four diﬀerent
experiments. Diﬀerent letters indicate signiﬁcant diﬀerences (P<
.001) calculated by ANOVA and Scheﬀ` e’s F-test (Statgraphics
package, STSC Inc., Rockville, Md, USA).
it has documented that a suppressive action of quercetin on
cytochrome P45, catalyzing the conversion of cholesterol to
pregnenolone, represents a rate-limiting step in the steroido-
genic pathway. Several recent studies [35, 38, 39] show
that the phytoestrogen-induced decrease of P4 production
in granulosa cells could result from an inhibition of 3β-
hydroxysteroid enzyme. On the contrary, Chen et al. [40]
evidenced that quercetin increases StAR mRNA expression
in MA-10 mouse tumor Leydig cells thus resulting in a
stimulatory eﬀect on steroidogenesis. This diﬀerence could
be due to a cell type-dependent action of the ﬂavonoid. As
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Figure 6: Eﬀect of the 48-hour treatment with quercetin (5
and 50μg/ml) on Vascular Endothelial Growth Factor (VEGF)
production by swine granulosa cell cultured in vitro. Data represent
the mean ± SEM of six replicates/treatment repeated in four dif-
ferent experiments. Diﬀerent letters indicate signiﬁcant diﬀerences
(P< . 001) calculated by ANOVA and Scheﬀ` e’s F-test (Statgraphics
package, STSC Inc., Rockville, Md, USA).
for E2 production, quercetin displayed a biphasic action:
in fact, our data show that low dosages appear to increase
E2 levels, while higher concentrations strongly decrease
E2 production. An inhibitory eﬀect of quercetin on aro-
matase activity in human granulosa-luteal cells has been
documented [39], but the mechanisms through which this
phytoestrogen could modulate the enzyme expression and
activity remain elusive: these could involve either a binding
with the estrogen receptors and/or a modulation of cell
signalling pathways. On the basis of our data, it is possible
to speculate that quercetin eﬀects on E2 production by
granulosa cells could be mediated by NO. In fact, this
free radical seems to represent an autocrine regulator of
granulosa cells E2 production [41], strongly inhibiting P450
aromatase activity [42]; the increase in estradiol secretion
by cultured human granulosa cell [42]t r e a t e dw i t hN O
synthase(NOS)inhibitors[43]wouldfurtherstrengthenthis
hypothesis. Interestingly, in agreement with our previous
works [44, 45], current data document that quercetin at
low doses strongly inhibits NO levels, while at higher doses
it stimulates NO release. These overall data would indicate
that quercetin can regulate aromatase activity , and thus
E2 release, by an interference with the NO/NOS system
in swine granulosa cells. Our results also document that
the increase of NO levels after treatment with 50μg/mL
of quercetin is paralled by a decrease of O2
− levels: this
observation would suggest a possible relationship between
these two ROSs. Quercetin has been shown [46]t op r o t e c t
nitric oxide (NO) from the scavenging actions of O2
−;
Vera et al. [47] reported that NO production negatively
aﬀectssuperoxideanion(O2
−)accumulationwitharesulting
formation of peroxynitrite (ONOO). Even if the antioxidant
potential of quercetin has been demonstrated by diﬀerent
studies [48, 49], pro-oxidative dose-dependent eﬀects were
also shown [7]. Present data indicate that quercetin does not6 Journal of Biomedicine and Biotechnology
aﬀectneitherH2O2 levelsnorSODactivity.Sinceantioxidant
scavenger gene expression depends mainly on ROS levels
[50], both the inhibitory eﬀect on O2
− generation as well
as the ineﬀectiveness in modulating H2O2 production could,
respectively,explain thelackofeﬀectonSODandperoxidase
enzyme activity. On the other hand, the higher quercetin
concentration increased total nonenzymatic antioxidant
ability thus suggesting that the antioxidant protection could
result from an increased ability of several molecules to
chelate transition metals [51].
Quercetin, at both concentrations tested, displayed a
strong inhibitory eﬀect on VEGF output thus suggesting its
involvement in the modulation of angiogenesis. Since fol-
licular development is strictly dependent on the angiogenic
process [25], driven mainly by VEGF, this ﬁnding acquires
particularrelevance,sinceitispossibletospeculateapossible
negative inﬂuence of quercetin on ovarian physiology. In
agreement with our ﬁndings, Zhong et al. [52] demonstrated
that quercetin treatment signiﬁcantly decreases VEGF secre-
tion by myeloblastic leukemia cells NB4 in vitro. In addition,
several studies document that ﬂavonoids inhibit VEGF-
induced endothelial cell functions and signalling pathways
acting at molecular level [53–56]. Moreover, quercetin was
found to inhibit several steps of angiogenesis, including
proliferation, migration, and diﬀerentiation of endothelial
cells [20, 57]. In conclusion, the present study demonstrates
that quercetin aﬀects porcine granulosa cell function by
interfering with steroidogenic activity and redox status as
well as by inhibiting VEGF output; these data would suggest
that this phytoestrogen represents a potential modulator of
ovarianfunctions.Furtherstudiesareneededtobetterdeﬁne
the in vivo eﬀe c t so fq u e r c e t i no nr e p r o d u c t i v ep h y s i o l o g y .
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